Patients in the immune-tolerant phase of hepatitis B virus infection should receive antiviral therapy to reduce viral load

Bibliographic Details
Main Author: LIN Bingliang
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2021-04-01
Series:Linchuang Gandanbing Zazhi
Online Access:http://www.lcgdbzz.org/cn/article/doi/10.3969/j.issn.1001-5256.2021.04.009

Similar Items